285: CRISPR history, biotech struggles, & a big week for deals
The Readout Loud
00:00
Introduction
The hosts discuss the expected FDA approval of the first CRISPR-based medicine, exploring the history of CRISPR and its implications for the future. They also speak to a biotech expert about the challenges faced by the industry and prospects for optimism.
Transcript
Play full episode
